Bank of New York Mellon Corp
BankPosition in ACAD — Acadia Pharmaceuticals Inc
CIK 1390777
NEW YORK, NY
Position in ACAD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$19,243,910
+$2,848,133 QoQ
Shares Held
760,629
+3.3% QoQ
Ownership
0.441%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. ACAD ranks #44 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,243,910 | 760,629 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $16,395,777 | 736,558 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $20,085,515 | 751,985 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $16,983,754 | 795,865 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $17,393,568 | 806,378 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $13,360,914 | 804,390 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $7,518,910 | 409,750 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $6,657,476 | 432,866 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,540,445 | 525,566 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $9,301,447 | 503,053 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $17,249,052 | 550,912 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $11,793,165 | 565,891 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $13,600,531 | 567,872 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $10,768,237 | 572,170 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $9,308,613 | 584,712 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $8,695,616 | 531,517 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,971,857 | 494,809 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,347,087 | 509,789 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $12,261,154 | 525,328 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,658,409 | 521,277 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $12,214,607 | 500,804 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $11,107,490 | 430,523 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $25,509,825 | 477,176 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $16,884,777 | 409,328 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $20,652,239 | 426,083 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $21,404,017 | 506,604 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||